Analysis of CD10+ hairy cell leukemia

被引:38
作者
Jasionowski, TM
Hartung, L
Greenwood, JH
Perkins, SL
Bahler, DW [1 ]
机构
[1] Univ Utah, Med Ctr, Dept Pathol, Salt Lake City, UT 84132 USA
[2] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA
关键词
CD10; flow cytometry; hairy cell leukemia;
D O I
10.1309/QVJD31TEG9UJ18BQ
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hairy cell leukemia (HCL) has been reported to sometimes express CD10. However the reported frequencies have been quite variable and the significance of CD10 expression has not been addressed. Cases of HCL submitted to our flow cytometry service during a 2-year period were evaluated for CD10 expression. Information regarding demographics, clinical manifestations, tissue morphologic features, and response to treatment was reviewed. Of the 97 HCL cases identified, 10 expressed CD10. The level of CD10 staining was typically well above control levels and also could be detected easily by immunohistochemical analysis. All cases analyzed were negative for bcl-6 Our study suggests that approximately 10% of otherwise typical cases of HCL show aberrant CD10 expression. CD10+ HCL cases seem to be morphologically and clinically similar to CD10- HCL cases. Appreciating that HCL can express CD10 may be especially important when evaluating specimens with suboptimal morphologic features and/or limited immunophenotyping panels.
引用
收藏
页码:228 / 235
页数:8
相关论文
共 20 条
[1]   Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients [J].
Berger, F ;
Felman, P ;
Thieblemont, C ;
Pradier, T ;
Baseggio, L ;
Bryon, PA ;
Salles, G ;
Callet-Bauchu, E ;
Coiffier, B .
BLOOD, 2000, 95 (06) :1950-1956
[2]  
BURKE JS, 1984, SEMIN ONCOL, V11, P334
[3]  
DiGiuseppe JA, 1998, SEMIN ONCOL, V25, P6
[4]   CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas [J].
Dogan, A ;
Bagdi, E ;
Munson, P ;
Isaacson, PG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (06) :846-852
[5]   Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses [J].
Forconi, F ;
King, CA ;
Sahota, SS ;
Kennaway, CK ;
Russell, NH ;
Stevenson, FK .
IMMUNOLOGY, 2002, 107 (01) :39-45
[6]   Primary plasma cell leukemia:: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics [J].
García-Sanz, R ;
Orfao, A ;
González, M ;
Tabernero, MD ;
Bladé, J ;
Moro, MJ ;
Fernández-Calvo, J ;
Sanz, MA ;
Pérez-Simón, JA ;
Rasillo, A ;
San Miguel, JF .
BLOOD, 1999, 93 (03) :1032-1037
[7]  
Jaffe ES., 2001, Tumors of haematopoietic and lymphoid tissues
[8]  
JULIUSSON G, 1994, BLOOD, V83, P3672
[9]  
Kaleem Z, 2001, AM J CLIN PATHOL, V115, P136
[10]  
Maloum K, 1998, BRIT J HAEMATOL, V101, P171